Phase 3 Arthritis trials

Showing 76 to 95 of 95. Each trial links to its page on Pharma Observatory.

• Evaluation of Walk With Ease in Arthritis NCT00526435·Phase 3·Completed·Centers for Disease Control and Prevention·Started 2007
• HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain NCT00792727·Phase 3·Completed·Hisamitsu Pharmaceutical Co., Inc.·Started 2007
• Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee NCT00504127·Phase 3·Completed·NicOx·Started 2007
• Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment NCT00450216·Phase 3·Completed·Amgen·Started 2007
• Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers NCT00450658·Phase 3·Completed·Amgen·Started 2007
• Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. NCT00367211·Phase 3·Completed·POZEN·Started 2006
• Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis NCT00445770·Phase 3·Completed·Pfizer·Started 2006
• Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis NCT00443950·Phase 3·Completed·Wyeth is now a wholly owned subsidiary of Pfizer·Started 2006
• Surgical Lavage vs Serial Needle Aspiration for Infected Joints NCT00313365·Phase 3·Withdrawn·Emory University·Started 2006
• Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients NCT00153660·Phase 3·Completed·Chinese University of Hong Kong·Started 2005
• Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain NCT00211718·Phase 3·Unknown status·Minneapolis Veterans Affairs Medical Center·Started 2004
• Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy NCT00646178·Phase 3·Completed·Abbott·Started 2003
• Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis NCT01015547·Phase 3·Completed·Helsinki University Central Hospital·Started 2003
• A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA NCT00652925·Phase 3·Completed·Pfizer·Started 2002
• Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib NCT00365313·Phase 3·Completed·Chinese University of Hong Kong·Started 2002
• Effect of Selective COX-2 Inhibition on Ulcer Healing NCT00153673·Phase 3·Completed·Chinese University of Hong Kong·Started 2001
• Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis. NCT00393471·Phase 3·Completed·Wyeth is now a wholly owned subsidiary of Pfizer·Started 2000
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus NCT00004662·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1996
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis NCT00004786·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1995
• Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease NCT00014742·Phase 3·Completed·State University of New York